ROBERT B. BRESSLER, M.D.; ROBERT J. AWE, M.D.
To the editor, The information obtained from the Nocturnal Oxygen Therapy Trial (1) does indeed seem to indicate that continuous oxygen therapy is associated with a lower mortality than nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. As stated by the authors, however, the reason for this difference is not clear. Further analysis of the data on pulmonary hemodynamics is needed, particularly pulmonary vascular resistance. The 11% decline in pulmonary vascular resistance in patients in continuous oxygen therapy is consistent with animal studies showing that continuous but not intermittent normoxemia may reverse anatomic evidence of pulmonary hypertension (1, 2).
BRESSLER RB, AWE RJ. Oxygen Therapy in Chronic Obstructive Lung Disease. Ann Intern Med. ;94:401. doi: 10.7326/0003-4819-94-3-410_1
Download citation file:
Published: Ann Intern Med. 1981;94(3):401.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use